Assessment of Reference Genes Stability in Cortical Bone of Obese and Diabetic Mice
Yuanli Ai,Kun Peng,Chunli Li,Jun Zhang,Gang Wang,Bin Wang,Enyi Huang
DOI: https://doi.org/10.2147/dmso.s453458
2024-03-02
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Yuanli Ai, 1, &ast Kun Peng, 2, &ast Chunli Li, 1, &ast Jun Zhang, 1 Gang Wang, 3, 4 Bin Wang, 1 Enyi Huang 3, 4 1 Institute of Life Sciences, College of Basic Medicine, Chongqing Medical University, Chongqing, People's Republic of China; 2 Chongqing Medical and Pharmaceutical College, Chongqing, People's Republic of China; 3 Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 4 Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education College of Stomatology, College of Stomatology, Chongqing Medical University, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bin Wang; Enyi Huang, Email ; Introduction: Bone, a pivotal structural organ, is susceptible to disorders with profound health implications. The investigation of gene expression in bone tissue is imperative, particularly within the context of metabolic diseases such as obesity and diabetes that augment the susceptibility to bone fractures. The objective of this study is to identify a set of internal control genes for the analysis of gene expression. Methods: This study employs reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR) to assess gene expression in bone tissue. We selected fourteen housekeeping genes and assessed their stability in the cortical bone of mouse models for obesity and diabetes using four well-established algorithms (GeNorm, BestKeeper, NormFinder, and the comparative Delta Ct method). Results and Conclusion: We identified Rpl13a as the mostly stably expressed reference gene in cortical bone tissue from mouse models of obesity and diabetes (db/db), while Gapdh was found to be the most stable reference gene in another diabetes model, KKAy mice. Additionally, Ef1a, Ppia, Rplp0 , and Rpl22 were identified as alternative genes suitable for normalizing gene expression in cortical bone from obesity and diabetes mouse models. These findings enhance RT-qPCR accuracy and reliability, offering a strategic guide to select reference gene for studying bone tissue gene expression in metabolic disorders. Keywords: reference genes, Rpl13a , Gapdh , cortical bone, metabolic disorders Gene expression serves as the pivotal regulator in orchestration of the intricate processes involved in bone morphogenesis, homeostasis, and repair; variations in gene expression led to different bone diseases. 1,2 Within the continually remodeling bone tissue, a harmonious interplay of distinct cellular cohorts, notably osteoblasts, osteoclasts, and osteocytes, mediates the synthesis and secretion of an array of extracellular matrix proteins, growth factors, and cytokines. 3 This complex process of bone homeostasis is meticulously governed at the transcriptional level, guided by a multifaceted interplay, involving transcription factors, epigenetic modulators, and elaborate signaling pathways. RNA, synthesized from DNA via transcription, is key in gene expression and comes in two forms: protein-coding and noncoding. Protein-coding genes produce messenger RNAs (mRNAs) which are translated into proteins, crucial for bone modeling and remodeling. 4,5 The expression of non-coding RNAs, including small, long, and circular types, is also involved in bone development and the pathogenesis of bone-related disorders. 6–8 Circular RNAs affect bone formation by regulating specific gene expression. 6 MicroRNAs (like miR-30, miR-124, miR-204) and long non-coding RNAs also play significant roles in bone growth and stability. 7,8 Dysregulations that disrupt this genetic equilibrium within the skeletal framework can engender a spectrum of skeletal disorders, encompassing conditions such as osteoporosis, osteoarthritis, and osteogenic neoplasms. 9 Hence, delving into the nuanced complexities of gene regulation in bone is crucial for the pursuit of pioneering therapeutic modalities for these incapacitating disorders. In recent years, an array of sophisticated gene expression analysis methodologies, 10 including microarray profiling, RNA sequencing, droplet digital PCR 11 and reverse transcription-quantitative real-time PCR (RT-qPCR), have substantially enriched our comprehension of the molecular substratum governing the dynamics of bone development, preservation, and pathological changes, offering the promise of groundbreaking strides in this field. When the expression levels of gen -Abstract Truncated-
endocrinology & metabolism